Select Page


Latisse® is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes, also known as hypotrichosis. It is indicated to treat hypotrichosis of the eyelashes by increasing their length, thickness and darkness.
Come in and ask Dr. Buono about Latisse®.


Latisse® is applied nightly, directly to the skin of the upper eyelid margin at the base of the eyelashes using the accompanying applicators. Blot any excess solution beyond the eyelid margin. Dispose of the applicator after one use. Repeat this technique on the opposite eyelid margin using a new sterile applicator.


Concurrent administration of LATISSE® and IOP-lowering prostaglandin analogs in ocular hypertensive patients may decrease the IOP-lowering effect. Patients using these products concomitantly should be closely monitored for changes to their intraocular pressure. Pigmentation of the eyelids and iris may occur. Iris pigmentation is likely to be permanent. (See product insert for more details).  Most common adverse reactions (incidence approximately 3% – 4%) are eye pruritus, conjunctival hyperemia, and skin hyperpigmentation. (6.1)



Call (312) 772-1133 to schedule your consultation today. We look forward to meeting you.